Barnet UNISON: Who are the Clinically Vulnerable?
Clinically extremely vulnerable receive updated guidance in line with new national restrictions
Further precautions advised on top of the tougher national measures being introduced, as cases continue to rise.
Those with the following conditions fall into the clinically extremely vulnerable group:
- solid organ transplant recipients
- people with specific cancers:
- people with cancer who are undergoing active chemotherapy
- people with lung cancer who are undergoing radical radiotherapy
- people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
- people having immunotherapy or other continuing antibody treatments for cancer
- people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
- people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
- people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
- people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell)
- people on immunosuppression therapies sufficient to significantly increase risk of infection adults with Down’s syndrome
- adults on dialysis or with chronic kidney disease (Stage 5)
- women who are pregnant with significant heart disease, congenital or acquired
- other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs. GPs and hospital clinicians have been provided with guidance to support these decision
Latest update added to clinical extremely vulnerable:
“We now have evidence to suggest that those with chronic kidney disease (stage 5) and those undergoing dialysis, as well as adults with Down’s Syndrome, are at higher risk from COVID-19 than the general population and therefore the Chief Medical Officer has advised they follow the new guidance for the clinically extremely vulnerable. We have asked the NHS to begin the process of identifying and contacting all those affected, providing them with the latest advice”.